Cargando…
Liver-Targeted Delivery of Oligonucleotides with N-Acetylgalactosamine Conjugation
[Image: see text] The potential therapeutic application of oligonucleotides (ONs) that selectively suppress target genes through antisense and RNA interference mechanisms has attracted great attention. The clinical applications of ONs have overcome multiple obstacles and become one of the most activ...
Autores principales: | Cui, Hao, Zhu, Xinying, Li, Shuyue, Wang, Peipei, Fang, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246477/ https://www.ncbi.nlm.nih.gov/pubmed/34235295 http://dx.doi.org/10.1021/acsomega.1c01755 |
Ejemplares similares
-
The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates
por: Zhang, Lei, et al.
Publicado: (2022) -
Asialoglycoprotein receptor 1 mediates productive uptake of N-acetylgalactosamine-conjugated and unconjugated phosphorothioate antisense oligonucleotides into liver hepatocytes
por: Tanowitz, Michael, et al.
Publicado: (2017) -
Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes
por: Clua, Anna, et al.
Publicado: (2022) -
Development of Triantennary N-Acetylgalactosamine
Conjugates as Degraders for Extracellular Proteins
por: Zhou, Yaxian, et al.
Publicado: (2021) -
Targeting Angiotensinogen With N-Acetylgalactosamine–Conjugated Small Interfering RNA to Reduce Blood Pressure
por: Ye, Dien, et al.
Publicado: (2023)